Indeed, we showed that either Mct1 deficiency or Mct1 inhibitor treatment could significantly alleviate the levels of anti-dsDNA autoantibody in the BM12-induced lupus-like mouse model. Here, SLC16A1 is linked to systemic lupus erythematosus.